GABRIELLE VICTOR: Open Payments
NPI 1205376712 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 29 payments from 11 companies in 2025. Trend: 2023 $251 · 2024 $1,110 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $207 |
| Novo Nordisk Inc | 6 | $136 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Abbott Laboratories | 2 | $43 |
| Amgen Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $32 |
| ABIOMED | 1 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: AIRSUPRA, Ozempic, TRELEGY ELLIPTA, BREZTRI, FREESTYLE LIBRE 3, OTEZLA, MOUNJARO, FARXIGA.
Industry payments across TN — which companies pay providers there.
